Approvals/NMPA/Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine

Approved

生物制品

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine

Merck Sharp & Dohme Corp🇨🇳 National Medical Products Administration

Approval Id: 7MaoUEaV43L
Approval Number: S20180009
Generic Name: 九价人乳头瘤病毒疫苗(酿酒酵母)
Generic Name En: Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 0.5 mL/瓶(西林瓶)
Reg Date: 2018-04-28
Company Name: Merck Sharp & Dohme Corp
Company Detail Path: /organization/merck-sharp-and-dohme-corp

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 28, 2018

Approval ID

7MaoUEaV43L

Type

生物制品